about
The deleterious role of basophils in systemic lupus erythematosusKit- and Fc epsilonRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cellsIgE receptor type I-dependent tyrosine phosphorylation of phospholipid scramblasePhospholipid scramblase 1 modulates a selected set of IgE receptor-mediated mast cell responses through LAT-dependent pathwayRegulation of microRNA expression and abundance during lymphopoiesis.Regulation of the tyrosine phosphorylation of Phospholipid Scramblase 1 in mast cells that are stimulated through the high-affinity IgE receptorImmunoglobulin E plays an immunoregulatory role in lupusAblation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.Phospholipid scramblase, a new effector of FcepsilonRI signaling in mast cells.Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis.PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeabilityNaive T cells sense the cysteine protease allergen papain through protease-activated receptor 2 and propel TH2 immunity.Mast cells as cellular sensors in inflammation and immunityMast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis.Phospholipid scramblase 1 amplifies anaphylactic reactions in vivo.Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxisMast cells in renal inflammation and fibrosis: lessons learnt from animal studies.The high-affinity immunoglobulin E receptor as pharmacological target.Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammationCD4+CXCR3+ T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus.p28, a novel IgE receptor-associated protein, is a sensor of receptor occupation by its ligand in mast cells.Basophils contribute to pristane-induced Lupus-like nephritis model.Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis.Early Phase Mast Cell Activation Determines the Chronic Outcome of Renal Ischemia-Reperfusion Injury.Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs.Non-IgE mediated mast cell activation.IgE in lupus pathogenesis: Friends or foes?Autoantibodies in SLE: Specificities, Isotypes and ReceptorsB LYMPHOCYTES UNDERGO APOPTOSIS BECAUSE OF Fc??RIIb stress response to infection: A novel mechanism of cell death in sepsisTomosyn functions as a PKCδ-regulated fusion clamp in mast cell degranulationTLR4 Receptor Induces 2-AG-Dependent Tolerance to Lipopolysaccharide and Trafficking of CB2 Receptor in Mast Cells
P50
Q27693310-75E3C404-CA89-49E7-B59B-4BEA0C6DD72FQ28116266-02C82CD6-D253-4A82-8DF3-87A32D774A4DQ28565124-98B32777-B4BD-40F1-922C-40860DD9ECE5Q28566197-0E56CF5A-A029-466C-AC66-D8B248B93F91Q34019233-EFE9DB07-ED4C-48C6-A2C5-806BD9AF32FCQ34301573-D43F470D-3D73-4C28-AE0A-4EE40385C2E4Q34375156-DF674D96-10BD-49CF-8B1F-21B4D2E90DFFQ34602106-E8427684-18CB-45A9-9A91-FBF5372B2A5EQ34825351-216929B0-67F5-4CB3-8448-9FC6A7866CE0Q35109029-B5BA307E-6523-4465-84FC-805EF45F2DB3Q35553313-4193410B-1DEF-452C-8C18-214B96A77B53Q35922964-574922FE-0773-4944-B010-47ADAF95D858Q35927571-4323D605-FDD5-4F93-9E6B-BBBE91B3A762Q36205829-F3F4D4BA-9345-4B92-BD18-8D8C0088F2DDQ36304517-C75A1BD0-C959-4A69-9919-55555803EBC2Q36505836-D1744DAA-871E-45AB-93DD-D747FC35336FQ38209110-9029A208-2FFB-4C35-B82D-27B1251AD19EQ38541084-752B5B85-0B22-4587-AF07-8F5EDE0027E5Q38623017-432ADFCD-7622-4E36-BA41-13E1E68B0A3AQ38983893-17F5BBB2-9201-48A9-BD5B-9D7AEF8366FDQ40600613-9CB96836-907D-422B-A4DD-742BC8B945D7Q41367448-9B5F5BB4-D670-4709-839B-12498F216F9CQ41757918-6E114A3E-233C-498D-B526-9F3524745E0EQ47693631-46BE2A7E-E004-4532-A78D-B9FD2E5EE423Q49789514-A8F1FB65-A5EB-4E96-945D-6C731A7B4B47Q50069011-41C8244E-F452-4AB8-A6DE-5F1B3E58E128Q50095973-0A80C06A-E4B6-420D-B6F2-2AF3270DA60FQ56806670-C0972B09-B305-492B-A8BF-D5AE8DE0BF17Q58861426-9ABB2DCF-6ECA-4A02-9145-5F91A6FF640DQ89410902-51FF9A3C-E202-4767-B11B-ABBBAD4E7CB5Q91984074-052FF588-7502-47C6-9F40-2A493E0D791F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nicolas Charles
@ast
Nicolas Charles
@en
Nicolas Charles
@es
Nicolas Charles
@nl
type
label
Nicolas Charles
@ast
Nicolas Charles
@en
Nicolas Charles
@es
Nicolas Charles
@nl
prefLabel
Nicolas Charles
@ast
Nicolas Charles
@en
Nicolas Charles
@es
Nicolas Charles
@nl
P106
P21
P31
P496
0000-0002-5416-5834